Clinical Trial Update: A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination [Phase 4]

View source ↗

Summary

A phase 4 trial comparing blood levels of nintedanib and pirfenidone when given separately or in combination for idiopathic pulmonary fibrosis; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Nintedanib (nintedanib)
• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2019-03-04